Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation

  • Received : 2018.10.11
  • Accepted : 2018.10.15
  • Published : 2018.11.05
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-9. https://doi.org/10.1056/NEJM199603143341104
  2. Lee HW, Suh KS. Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 2016;22(3):309-18. https://doi.org/10.3350/cmh.2016.0042
  3. Kang SH, Cho H, Cho EJ, Lee JH, Yu SJ, Kim YJ, et al. Efficacy of sorafenib for the treatment of post-transplant hepatocellular carcinoma recurrence. J Korean Med Sci 2018;33(45):e283. https://doi.org/10.3346/jkms.2018.33.e283
  4. Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg 2015;220(4):416-27. https://doi.org/10.1016/j.jamcollsurg.2014.12.025
  5. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, et al. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) score for hepatocellular carcinoma recurrence after liver transplant. JAMA Oncol 2017;3(4):493-500. https://doi.org/10.1001/jamaoncol.2016.5116
  6. Yoo JJ, Chung GE, Lee JH, Nam JY, Chang Y, Lee JM, et al. Sub-classification of advanced-stage hepatocellular carcinoma: a cohort study including 612 patients treated with sorafenib. Cancer Res Treat 2018;50(2):366-73. https://doi.org/10.4143/crt.2017.126
  7. Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, et al. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma. Liver Int 2013;33(6):950-7. https://doi.org/10.1111/liv.12168
  8. Toso C, Cader S, Mentha-Dugerdil A, Meeberg G, Majno P, Morard I, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci 2013;20(3):342-7. https://doi.org/10.1007/s00534-012-0528-4

Cited by

  1. The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants vol.38, pp.7, 2018, https://doi.org/10.1007/s12325-021-01800-z